title: Development and validation of a simple and isocratic reversed-phase HPLC method for the determination of rilpivirine from tablets, nanoparticles and HeLa cell lysates.
abstract: In the present investigation, a simple and isocratic HPLC-UV method was developed and validated for determination of rilpivirine (RPV) from dosage forms (tablets and nanoparticles) and biological matrices like HeLa cell lysates. The separation and analysis of RPV was carried out under isocratic conditions using (a) a Gemini reversed-phase C18 column (5 µm; 4.6 × 150 mm) maintained at 35°C, (b) a mobile phase consisting of a mixture of acetonitrile and 25 m m potassium dihydrogen phosphate (in the ratio 50:50 v/v) at a flow rate of 0.6 mL/min and (c) atazanavir as an internal standard. The total run time was 17 min and the analysis of RPV and internal standard was carried out at 290 nm. The method was found to be linear (r(2) value > 0.998), specific, accurate and precise over the concentration range of 0.025-2 µg/mL. The lower limit of quantification was 0.025 µg/mL, the limit of detection was 0.008 µg/mL and the recovery of RPV was >90%. The stability of the RPV analytical method was confirmed at various conditions such as room temperature (24 h), -20°C (7 days), three freeze-thaw cycles and storage in an autosampler (4°C for 48 h). The method was successfully applied for the determination of RPV from conventional dosage forms like tablets, from polymeric nanoparticles and from biological matrices like HeLa cell lysates.
authors.affiliation: School of Pharmacy and Health Professions, Creighton University, Omaha, NE, 68178, USA.
authors.forename: Abhijit A
authors.initials: AA
authors.lastname: Date
authors.forename: Annemarie
authors.initials: A
authors.lastname: Shibata
authors.forename: Patrick
authors.initials: P
authors.lastname: Bruck
authors.forename: Christopher J
authors.initials: CJ
authors.lastname: Destache
mesh_terms: D002477:Cells / Q000737:chemistry*; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D006367:HeLa Cells; D006801:Humans; D053758:Nanoparticles / Q000032:analysis*; D000068696:Rilpivirine / Q000032:analysis*; D012680:Sensitivity and Specificity; D013607:Tablets / Q000032:analysis*
chemical_list: D013607:Tablets; D000068696:Rilpivirine
keywords: detection method; isocratic HPLC; rilpivirine